Skip to content
Screener

Axsome Therapeutics AXSM Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.83B+10.7%
Alkermes logo
AlkermesALKS
$110.9M+55.5%
AbbVie logo
AbbVieABBV
$150M-97.3%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$13.55M+16.7%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$16.8M+2.0%

Other financials

Income statement

See full
Revenue$191.2M+57.4%
Gross profit$176.5M+58.0%
Operating income-$63.4M-11.2%
Net income-$64.5M-8.6%
EPS (diluted)-$1.26-3.3%

Balance sheet

See full
Cash & equivalents$305.1M+1.4%
Total debt$219.9M+4.1%
Total equity$54.6M+2.6%
Total assets$713.6M+19.6%

Cash flow

See full
Operating cash flow-$20.7M+52.3%
CapEx$121.0K-64.2%
Free cash flow-$20.8M+52.4%

Valuation

See full
Market cap$10.95B+113%
Enterprise value$10.87B+114%
P/S15.5×+5.1×

Profitability

See full
Gross margin92.6%+1.1pp
Operating margin-24.4%-9.3pp
Net margin-26.6%-9.8pp
FCF margin-10.2%-3.9pp

Returns & leverage

See full
Return on equity-349.4%+109pp
Debt / equity+0.1×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Axsome Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 5:04 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-204274
Line itemMarch 31,2026December 31,2025
Cash and cash equivalents$305,106$322,933
Accounts receivable, net251,062224,464
Inventories, net31,51527,938
Prepaid and other current assets23,52313,651
Total current assets611,206588,986
Equipment, net567562
Right-of-use asset - operating lease20,01420,858
Goodwill12,04212,042

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Axsome Therapeutics's prepaid & other current?
Axsome Therapeutics (AXSM) reported prepaid & other current of $23.52M in Q1 2026.
How has Axsome Therapeutics's prepaid & other current changed year-over-year?
Axsome Therapeutics's prepaid & other current increased by 47.0% year-over-year, from $16.01M to $23.52M.
What is the long-term trend for Axsome Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Axsome Therapeutics's prepaid & other current has grown at a 147.0% compound annual growth rate (CAGR), from $148.37K to $13.65M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Axsome Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude